Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kypha logo — Precision Immune Monitoring Delivered

Kypha

Precision Immune Monitoring Delivered

Founded 2009 United States United States 15 employees Series Unknown Total: $24.01M Biotechnology, Health Care +1

General Information

Company Name Kypha
Founded Year 2009
Location United States United States +2
Employees 15
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Kypha moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kypha

Kypha, founded in 2009, operates at the forefront of precision biotechnology, focusing on immune system insights. Headquartered in the United States, this company has carved a niche within the Biotechnology, Health Care, and Medical Devices industries.

With the slogan "Precision Immune Monitoring Delivered," Kypha specializes in real-time analysis of immune signals, specifically targeting complement proteins, cytokines, and chemokines. Their CompAct® and RapiPlex platforms provide rapid, point-of-care assessments that dramatically enhance the precision of immune status evaluations, guiding more informed clinical and therapeutic decisions.

Their most recent financial leap was marked by a $5.15M venture round investment in May 2022, underscoring investor confidence. Kypha's innovative approach positions it as a promising partner for those looking to drive advancements in real-time immune monitoring and therapeutic developments.

Taxonomy: Precision Medicine, Immune Monitoring, Complement System, Point-of-Care Diagnostics, Autoimmune Disorders, Inflammatory Disorders, Real-Time Diagnostics, Cytokine Analysis, Chemokine Analysis, Immune Status Assessment, Diagnostic Technology, Clinical Intervention, FDA Clearance, Life Sciences Innovation, Therapeutic Decision Making

Services & Products

assay development and manufacturing
custom panel development
exploratory biomarker analysis
current biomarker detection

Target Customers

therapeutic developers clinical healthcare providers biotech companies immunology researchers

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 12 May 2022
Series A •••••• 1
Investor
20 Dec 2018
Venture Round •••••• - 20 Jul 2018
Venture Round •••••• 2
Investor Investor
07 May 2018
Venture Round •••••• 1
Investor
20 Oct 2017

View All 15 Funding Rounds

Kypha Alternatives & Competitors

Kypha vs
Inflammatix, Inc.
Inflammatix, Inc. United States

We’re reimagining diagnostics by reading the immune system

Grant
96 employees
Big Data, Biotechnology
Kypha vs
Proactive Diagnostics
Proactive Diagnostics United States

Enabling At-Home Personal Inflammation Monitoring that is Accurate, Fast and Affordable

Series Unknown
3 employees
Health Care
Kypha vs
DxTerity
DxTerity United States

Bringing the power of precision medicine to autoimmune disease

Series Unknown
31 employees
Biotechnology, Health Care

FAQ About Kypha

Precision Immune Monitoring Delivered
Kypha was founded in 2009.
Kypha is headquartered in United States.
Kypha operates in the following industries: Biotechnology, Health Care, Medical Devices.
Kypha has approximately 15 employees.
Kypha has completed 15 funding rounds, raising a total of $24.01M. The latest funding stage is Series Unknown.
Kypha offers: assay development and manufacturing, custom panel development, exploratory biomarker analysis, current biomarker detection.
Top alternatives and competitors to Kypha include Inflammatix, Inc., Proactive Diagnostics, DxTerity, Senzo Health, Pear Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kypha and Inflammatix, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kypha and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy